Moderna, Merck say their cancer vaccine reduces metastases by 65% in PhII study of high-risk melanoma: #ASCO23 – Endpoints News June 5, 2023
Slow TCA flux and ATP production in primary solid tumours but not metastases February 2, 2023February 1, 2023